Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 4.99M | $3.64B | 8.07% | -601.3K | 2026-03-31 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3.37M | $2.46B | 5.45% | +12.6K | 2026-03-31 |
| JANUS HENDERSON GROUP PLC | 2.54M | $1.85B | 4.11% | +83.6K | 2026-03-31 |
| Capital World Investors | 2.26M | $1.65B | 3.65% | +340.0K | 2026-03-31 |
| Artisan Partners Limited Partnership | 1.47M | $1.07B | 2.37% | -289.0K | 2026-03-31 |
| WELLINGTON MANAGEMENT GROUP LLP | 1.02M | $745.0M | 1.65% | +342.2K | 2026-03-31 |
| Avoro Capital Advisors LLC | 1.00M | $730.0M | 1.62% | +10.0K | 2026-03-31 |
| BlackRock, Inc. | 808.3K | $590.0M | 1.31% | +72.7K | 2026-03-31 |
| RTW INVESTMENTS, LP | 709.4K | $518.0M | 1.15% | +35.9K | 2026-03-31 |
| Invesco Ltd. | 594.7K | $434.0M | 0.96% | +178.3K | 2026-03-31 |
